Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06434181 · ClinicalTrials.gov registry record · Phase 2
Beetroot Juice for Boosting Immunity During a Time of Stress.
A Phase 2 study, sponsored by Baylor University.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
NCT06434181: Completed Phase 2 study, sponsored by Baylor University.
NCT06434181 is a Phase 2 study that has completed, run by Baylor University. The registered enrollment target is 114 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06434181, a Phase 2 study, has completed, sponsored by Baylor University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of the present study is to explore the effects of a dietary nitrate supplement (i.e., beetroot juice) on nitric oxide levels, immunity, mood, and cardiovascular activity during and following final exam stress in healthy individuals.
Primary Outcome
Assesses symptoms of acute upper respiratory tract infections (common cold symptoms) by questionnaire
Interventions
- DIETARY_SUPPLEMENT Placebo Control
- DIETARY_SUPPLEMENT Beetroot Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2022-12-13 |
| Phase | Phase 2 |
What the finished NCT06434181 record still lists
NCT06434181 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Control is the first listed.
NCT06434181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06434181 about?
NCT06434181 is a clinical study titled "Beetroot Juice for Boosting Immunity During a Time of Stress.". The purpose of the present study is to explore the effects of a dietary nitrate supplement (i.e., beetroot juice) on nitric oxide levels, immunity, mood, and cardiovascular activity during and following final exam stress in healthy individuals.
What is the current status of trial NCT06434181?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2022-04-11. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT06434181?
The interventions under investigation include: Placebo Control (DIETARY_SUPPLEMENT), Beetroot Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06434181?
This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06434181's enrollment target sits among peer trials
114 627th of 2000 higher than 1,370 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI